English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFirst, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have been marketed and widely used for weight loss. Now these medications are showing promise as a possible treatment for multiple sclerosis. A study, “Exploring the association…
Tag: MS
Uncovering why more Black women than ever are being diagnosed with multiple sclerosis
Women are more likely than men to get diagnosed with multiple sclerosis (MS), an incurable disease that affects the central nervous system.
Research and customized care make aging with Multiple Sclerosis better
Physician scientists at The Ohio State University Wexner Medical Center and College of Medicine are studying why multiple sclerosis (MS) worsens as patients grow older. The “Aging with MS Clinic” provides complete care for older adults with MS.
Using Ion Beams to Improve Brain Microscopy
Improving the way scientists can see the microscopic structures of the brain can improve our understanding of a host of brain diseases, like Alzheimer’s or multiple sclerosis. Studying these diseases is challenging and has been limited by accuracy of available models.To see the smallest parts of cells, scientists often use a technique called electron microscopy.
Life stressors may contribute to multiple sclerosis flares, disability
Stressors across the lifespan — including poverty, abuse and divorce — are associated with worsening health and functional outcomes for people with multiple sclerosis, a new study finds. Researchers say the findings can inform MS research as well as clinical care, including referrals to mental health or substance use support.
Genomic Analysis of Multiple Sclerosis Reveals Possible Biomarkers
A better understanding of the genetic biomarkers underpinning multiple sclerosis (MS) may lead to predictors of disease that could improve management of the condition, according to new research presented at Physiatry ’23, the Association of Academic Physiatrists (AAP) annual meeting.
MS Center at Jersey Shore University Medical Center Nationally Recognized as a Center for Comprehensive MS Care
Hackensack Meridian Jersey Shore University Medical Center’s Multiple Sclerosis Center, a leading provider of care for people living with multiple sclerosis (MS) in New Jersey, has been officially recognized as a Center for Comprehensive MS Care through the National Multiple Sclerosis Society’s Partners in MS Care program. It is one of only two Centers for Comprehensive MS Care in Monmouth and Ocean counties.
Stem Cell Transplants May Delay Disability Longer than Some MS Medications
In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a study published in the December 21, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study involved autologous hematopoietic stem cell transplants, which use healthy blood stem cells from a person’s own body to replace diseased cells.
ACTRIMS Forum 2023 themed MS: Going Viral
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum will be held Feb. 23-25, 2023, in San Diego, California at the Marriott Marquis San Diego Marina. Themed “MS: Going Viral,” the Forum 2023, will address the role of different viruses that have been implicated in the ongoing disease process in MS, in particular the Epstein-Barr virus, which has been associated with the onset of MS. The Forum also features the Kenneth P. Johnson Memorial Lecture, which will be delivered by Dr. Lawrence Steinman.
Does Multiple Sclerosis Play a Role in Cancer Screening and Diagnosis?
Women with multiple sclerosis (MS) are less likely to have breast cancers detected through cancer screenings than women without MS, according to new research published in the April 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. Conversely, researchers also found that people with MS are more likely to have colorectal cancers detected at an early stage than those without MS.
Study Finds Rate of Multiple Sclerosis Similarly High in Black and White People
The rate of multiple sclerosis (MS) cases varies greatly by race and ethnicity. A new study suggests that the prevalence of MS in Black and white people is similarly high, while much lower in Hispanic and Asian people. The research is published in the April 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Hopkins Med News Update
Hopkins Med News Update
Study may show why MS patients develop progressive disability but those with related diseases do not
Did you know multiple sclerosis (MS) means multiple scars? New research shows that the brain and spinal cord scars in people with MS may offer clues to why they developprogressive disability but those with related diseases where the immune system attacks the central nervous system do not.
In a study published in Neurology, Mayo Clinic researchers and colleagues assessed if inflammation leads to permanent scarring in these three diseases:
Q&A with Leaders of MS Virtual 2020 Conference
ACTRIMS MS Virtual 2020 Q&A with Association Leadership
Multi-sensor Band Quickly and Simply Records Subtle Changes in Patients with MS
An international team of scientists, led by UC San Diego researchers, has developed a new, multi-sensor tool that measures subtle changes in multiple sclerosis patients, allowing physicians to more frequently and more quickly respond to changes in symptoms or patient condition.
New drug that could aid earlier MS diagnoses approved by FDA for first human clinical trials
A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages has been approved for its first human trials by the U.S. Food and Drug Administration (FDA).
Flashing lights may provide vital first test of MS drug success
Measuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis (MS), according to researchers at the University of Wisconsin–Madison, and could be used to evaluate new treatments for the disease.
Jersey Shore University Medical Center Opens MS Center, Welcomes David Duncan, M.D.
Hackensack Meridian Health Jersey Shore University Medical Center recently opened a new Multiple Sclerosis (MS) Center and welcomed MS Certified Specialist David Duncan, M.D., as director of the center.